Association Between Bacillus Calmette-Guérin Vaccination and Childhood Asthma in the Quebec Birth Cohort on Immunity and Health

We estimated the association between bacillus Calmette-Guérin (BCG) vaccination and childhood asthma in a birth cohort using administrative databases, and we determined the impact of adjusting for potential confounders collected from a subset of the cohort members. Data were collected in 2 waves: 1) Administrative data for 76,623 individuals (stage 1) was gathered from the Quebec Birth Cohort on Immunity and Health (1974-1994), including BCG vaccination status, perinatal and sociodemographic characteristics, and use of health services for asthma; and 2) self-reported asthma risk factors were collected in 2012 by telephone interviews with 1,643 participants (stage 2) using a balanced 2-stage sampling design. We estimated odds ratios and 95% confidence intervals for asthma using logistic regression and correcting for the known sampling fractions from stage 1 to stage 2, overall and sex-stratified. In total, 35,612 (46.5%) individuals were BCG vaccinated, and 5,870 (7.7%) had asthma. The final odds ratio, integrating results from both stages of sampling, was 0.95 (95% confidence interval: 0.87, 1.04). Results did not differ according to sex (P for interaction = 0.327). To our knowledge, this is the largest study ever conducted on this topic, and using the best possible comprehensive adjustment for confounders, we found no association between BCG vaccination and asthma.

[1]  A. Benedetti,et al.  Evaluating the Validity of a Two-stage Sample in a Birth Cohort Established from Administrative Databases , 2016, Epidemiology.

[2]  J. Guthmann,et al.  Validity of self-reported vaccination status among French healthcare students. , 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[3]  A. Benedetti,et al.  Determinants of Bacillus Calmette-Guérin (BCG) vaccination among Québec children. , 2014, Preventive medicine.

[4]  Jun Li,et al.  The Québec BCG Vaccination Registry (1956–1992): assessing data quality and linkage with administrative health databases , 2014, BMC Medical Informatics and Decision Making.

[5]  A. Crain,et al.  Self-report compared to electronic medical record across eight adult vaccines: do results vary by demographic factors? , 2013, Vaccine.

[6]  H. Whittle,et al.  Small Randomized Trial Among Low–birth-weight Children Receiving Bacillus Calmette-Guérin Vaccination at First Health Center Contact , 2012, The Pediatric infectious disease journal.

[7]  F. Shann.  The non-specific effects of vaccines , 2010, Archives of Disease in Childhood.

[8]  Sanjeev K. Gupta,et al.  Does BCG vaccination protect against childhood asthma? , 2010, The National medical journal of India.

[9]  Andrea Benedetti,et al.  Does BCG vaccination protect against the development of childhood asthma? A systematic review and meta-analysis of epidemiological studies. , 2010, International journal of epidemiology.

[10]  Teresa To,et al.  Identifying patients with physician-diagnosed asthma in health administrative databases. , 2009, Canadian respiratory journal.

[11]  Zoran Bursac,et al.  Purposeful selection of variables in logistic regression , 2008, Source Code for Biology and Medicine.

[12]  A. Henderson.  What have we learned from prospective cohort studies of asthma in children? , 2008, Chronic respiratory disease.

[13]  Yves St-Pierre,et al.  Potential health effects from non‐specific stimulation of the immune function in early age: The example of BCG vaccination , 2008, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[14]  H. Shen,et al.  Neonatal vaccination with Bacillus Calmette‐Guérin elicits long‐term protection in mouse‐allergic responses , 2008, Allergy.

[15]  Y. Ohya,et al.  Tuberculin reactivity and allergic disorders in schoolchildren, Okinawa, Japan , 2008, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[16]  R. Balicer,et al.  Is Childhood Vaccination Associated With Asthma? A Meta-analysis of Observational Studies , 2007, Pediatrics.

[17]  H. van Loveren,et al.  Bacille–Calmette–Guerin vaccination and the development of allergic disease in children: a randomized, prospective, single‐blind study , 2007, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[18]  L. Irving,et al.  The natural history of asthma from childhood to adulthood , 2007, International journal of clinical practice.

[19]  C. Lemière,et al.  Validity of asthma diagnoses recorded in the Medical Services database of Quebec , 2006, Pharmacoepidemiology and drug safety.

[20]  James A Hanley,et al.  Two-stage case-control studies: precision of parameter estimates and considerations in selecting sample size. , 2005, American journal of epidemiology.

[21]  F. Guillén-Grima,et al.  BCG Immunization at Birth and Atopic Diseases in a Homogeneous Population of Spanish Schoolchildren , 2005, International Archives of Allergy and Immunology.

[22]  Rodney X. Sturdivant,et al.  Applied Logistic Regression: Hosmer/Applied Logistic Regression , 2005 .

[23]  M. Newport,et al.  Acute lower respiratory tract infections and respiratory syncytial virus in infants in Guinea-Bissau: a beneficial effect of BCG vaccination for girls community based case-control study. , 2005, Vaccine.

[24]  M. Barreto,et al.  Lower prevalence of reported asthma in adolescents with symptoms of rhinitis that received neonatal BCG , 2004, Allergy.

[25]  B. Toelle,et al.  The effect of neonatal BCG vaccination on atopy and asthma at age 7 to 14 years: an historical cohort study in a community with a very low prevalence of tuberculosis infection and a high prevalence of atopic disease. , 2003, The Journal of allergy and clinical immunology.

[26]  U. Wahn,et al.  Is early BCG vaccination associated with less atopic disease? An epidemiological study in German preschool children with different ethnic backgrounds , 2002, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[27]  R W Platt,et al.  A new and improved population-based Canadian reference for birth weight for gestational age. , 2001, Pediatrics.

[28]  P. Holt,et al.  The development of the immune system during pregnancy and early life , 2000, Allergy.

[29]  G. Gros,et al.  Development of an Asthma Vaccine , 2000, Drugs.

[30]  M. Newport,et al.  Newborns develop a Th1-type immune response to Mycobacterium bovis bacillus Calmette-Guérin vaccination. , 1999, Journal of immunology.

[31]  J. Boivin,et al.  Controlling Confounding When Studying Large Pharmacoepidemiologic Databases: A Case Study of the Two‐Stage Sampling Design , 1998, Epidemiology.

[32]  D A Savitz,et al.  Risk Factors for Preterm Birth Subtypes , 1998, Epidemiology.

[33]  J. Holloway,et al.  Infection of Mice with Mycobacterium bovis–Bacillus Calmette-Guérin (BCG) Suppresses Allergen-induced Airway Eosinophilia , 1998, The Journal of experimental medicine.

[34]  G. Pershagen,et al.  Early BCG vaccination and development of atopy , 1997, The Lancet.

[35]  P. Burton,et al.  The natural history of respiratory symptoms in preschool children. , 1995, American journal of respiratory and critical care medicine.

[36]  W. Morgan,et al.  Asthma and wheezing in the first six years of life. The Group Health Medical Associates. , 1995, The New England journal of medicine.

[37]  R. Carroll,et al.  The partial questionnaire design for case-control studies. , 1994, Statistics in medicine.

[38]  R Menzies,et al.  Effect of bacille Calmette-Guérin vaccination on tuberculin reactivity. , 1992, The American review of respiratory disease.

[39]  D. Hosmer,et al.  Applied Logistic Regression , 1991 .

[40]  S Greenland,et al.  Modeling and variable selection in epidemiologic analysis. , 1989, American journal of public health.

[41]  K. Beswick,et al.  CHILDHOOD ASTHMA , 1983, The Lancet.

[42]  A. M. Walker,et al.  Anamorphic analysis: sampling and estimation for covariate effects when both exposure and disease are known. , 1982, Biometrics.

[43]  A. Frappier,et al.  The study and use of BCG in Canada. , 1966, Canadian journal of public health = Revue canadienne de sante publique.

[44]  A. Frappier,et al.  [Influence of BCG vaccination on the mortality from meningeal tuberculosis in children from 0 to 10 years of age in the Province of Quebec]. , 1962, Canadian Medical Association journal.

[45]  A. Sheikh,et al.  BCG vaccination and allergy: a systematic review and meta-analysis. , 2011, The Journal of allergy and clinical immunology.

[46]  S. Willsie.  Wheezy babies–Wheezy adults? Review on long-term outcome until adulthood after early childhood wheezing , 2009 .

[47]  G. Le Gros,et al.  Development of an asthma vaccine: research into BCG. , 2000, Drugs.

[48]  W. Millar,et al.  Childhood asthma. , 1998, Health reports.

[49]  P. Malissard.  [The long controversy over anti-tuberculosis vaccination in Canada: the Calmette-Guerin bacillus (BCG), 1925-1975]. , 1998, Canadian bulletin of medical history = Bulletin canadien d'histoire de la medecine.

[50]  P. Malissard.  La longue controverse de la vaccination antituberculeuse au Canada : le bacille Calmette-Guérin (BCG), 1925-1975. , 1998 .

[51]  N. Galambos,et al.  Multiple-risk behaviour in adolescents and young adults. , 1998, Health reports.

[52]  Ayne,et al.  ASTHMA AND WHEEZING IN THE FIRST SIX YEARS OF LIFE , 1995 .

[53]  J E White,et al.  A two stage design for the study of the relationship between a rare exposure and a rare disease. , 1982, American journal of epidemiology.